| Name | Title | Contact Details |
|---|
Bronzini Dental Group is a Millbrae, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Joerns Healthcare is a leading manufacturer and national service provider of patient handling and wound care products to the healthcare continuum. It helps healthcare providers solve complex medical equipment challenges, improve patient and caregiver safety, and speed patient healing with its renowned Purple Shirt service and efficient spend management. Headquartered in Charlotte, North Carolina with 1700 employees throughout North America and Europe, Joerns Healthcare is committed to delivering solutions that improve the lives of patients and care providers.
J and B Medical Supply, Inc. is a Wixom, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Emboline is a medical device company with a game-changing device for total embolic protection during percutaneous heart valve repair and replacement procedures and other cardiovascular procedures with embolic risks.
NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.